Abstract: Coronavirus disease 2019 (Covid19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a single-stranded RNA virus. There is no vaccine or specific antiviral treatment for Covid19 that is causing a global pandemic. One current focus is drug repurposing research. Among existing drugs, chloroquine and hydroxychloroquine, used for the prevention and treatment of malaria, rheumatoid arthritis and lupus erythematosus, have been intensely re-purposed for experimental treatment of Covid19. However, these drugs have well-known adverse effects (e.g., retinopathy), and unknown dose-response relationships, poorly defined doses needed for clinical efficacy and toxic tolerance also pose challenges to clinical practice. The pathology of Covid19 is essentially unknow. Without this understanding, it is hard to discover a successful treatment to be approved for clinical use.
), hydrogen peroxide (H2O2) and hydroxyl radical (OH  ), are constantly produced from aerobic metabolism of the cell. It is known that OH  is potent but non-selective oxidant, while O2 − and H2O2 are far less reactive. Moreover, increasing evidence over the past decade has showed that H2O2 is a necessary signaling molecule ('evil') in the regulation of a variety of biological processes such as cell proliferation and differentiation, tissue repair, immune cell activation, circadian rhythm, vascular remodeling and aging. [1] [2] [3] [4] [5] H2O2 is also a signaling molecule of plant defense against pathogens. 6 Respiratory burst is the rapid release of reactive species from different types of cells. It is usually utilised for immunological defence. The exposure to ROS or reactive halogen species (RHS) or reactive nitrogen species (RNS) kills the engulfed pathogens, resulting in pathology of infection. Similar 'respiratory bust' is found when cells are exposed to ionizing radiation (IR) at a clinical dose 7 or when the ozone layer is exposed to ionizing cosmic rays in the polar stratosphere especially with the presence of halogenated molecules (particularly freons, CFCs) [8] [9] [10] [11] . Respiratory burst occurs mainly in one type of immune cells, called myeloid cells such as neutrophils, monocytes, macrophages, mast cells, and dendritic cells. Phagocytosis plays a major role in the innate immune defense to most infections by effectively killing of pathogens in cells. The phagosome then moves toward the centrosome and fuses with lysosomes, forming a phagolysosome for degradation of pathogens.
For O2-dependent degradation, it depends the production of ROS, RHS and RNS. After phagocytosis of pathogens, the NADPH oxidases (NOX2) embedded in the phagolysosome membrane is activated to produce O2 . H2O2 is generated from O2
•− via superoxide dismutases (SOD) or hemeperoxidases (MPO and EPO); OH  is then generated via the Haber-Weiss reaction. Through MPO/EPO, H2O2 activates a halogenating system, which generates hypochlorous acid (HOCl) and kills pathogens. [12] [13] [14] [15] The inducible nitric oxide synthases (iNOS) also catalyze the reaction of NO  with O2 − to produce a toxic peroxynitrite (ONOO − ) that then forms NO2 via reaction with CO2. [16] [17] [18] All OH
• , HOCl and ONOO − (NO2) are strong oxidants to cause damages in DNA/RNA and proteins and anti-pathogen effects. [12] [13] [14] [15] [16] [17] [18] Particularly, the enzyme MPO is most abundant in neutrophils. HOCl has widely been used as a strong disinfectant, particularly lethal for E. coli due to inactivation of many vital systems. [12] [13] [14] [15] Also, HOBr and HOI at lower levels were recently detected in stimulated immune cells (leukocytes). 14 Macrophages usually produce far lower levels of radicals than neutrophils and require activation for their antiviral properties. This is made by their transient respiratory burst, which regulates the inflammatory response by inducing synthesis of cytokines for redox signalling, giving rise to an influx of neutrophils and activated macrophages. Due to the high toxicity of generated reactive species, neutrophils have a short life span to limit damage to host tissue during inflammation.
Of particular interest is the role of endogenous RHS in the oxygen-dependent killing mechanisms of invading pathogens. In fact, HOXs (X=Cl, Br) are important halogen species causing ozone depletion in the Earth's stratosphere. They are derived from solar photolysis 19, 20 or cosmic-ray driven dissociative-electron-transfer (DET) reactions [8] [9] [10] [11] of halogen-containing organic molecules, especially CFCs. In radiation biology, there is a long mystery that the production of primary and secondary ROS/RNS by IR is insignificant compared with the levels produced routinely by oxidative metabolism of cells. 7 The lethal radiation dose of 4 Gy initially generates, at most, as much ROS as humans normally produce in about 80 seconds in the same volume, averaged over the cell! This leads to the question of how the few primary ionization events produced at clinically relevant doses is amplified to account for observed biological effects. The mechanism remains elusive. 7 This reminds the exact situation in the 1970s when atmospheric scientists could not explain some significant ozone loss observed in the Earth's stratosphere until the birth of modern ozone depletion theory. An amplifying mechanism is now established that a Cl atom can catalytically destroy up to 100000 ozone molecules via halogen reaction cycles.
Here we propose that (i) the initial yields of endogenous reactive species produced in the phagosome are not sufficient to cause a significant anti-pathogen (especially antiviral) effect in the innate immune defense, for which an amplification mechanism is required; (ii) The O3-depletinglike reaction cycles of RHS take place in the phagosome for immunological defence in cells of humans and all other mammals, with some necessary modifications associated with enzymes instead of solar photons or cosmic rays; (iii) Similar to the formation of polar O3 hole, the reaction cycles of RHS (mainly X All of these RHS have been found in biological systems. [12] [13] [14] [15] [21] [22] [23] [24] As established in O3 depleting reactions, RHS can have many cyclic reactions in cells with enzymes replacing solar photons or cosmic-ray-produced electrons. For example, X  and HOX with X=Cl, Br, or I can have the following cyclic reactions with enzymes such as MPO/EPO/NOX/NADPH (bold represents altered targets such as damaged DNA/RNA/proteins):
Net: H2O2 + R1NH + R2NH  R1NX + R1NR2NH for (3a-3b, and 3d-3f) plus (1) and (2) R1NH + R2NH + R3NH +…  R1NX + R2NX+ R3NX+ … for (3a-3c and 3g-3j)
Net: H2O2 + R1NH + R2NH  R1NX + R1NR2NH for (4a-4b, and 4d-4f) plus (1) and (2) R1NH + R2NH + R3NH +…  R1NX + R2NX+ R3NX+ … for (4a-4c and 4g-4j)
Note that cycle 1 including reactions (3a-3b and 3d-3f) or (4a-4b and 4d-4f) depends on H2O2, whereas cycle 2 including reactions (3a-3c and 3g-3j) or (4a-4c and 4g-4j) are H2O2 independent due to the DET of RN1X into a X  atom. In any case, however, the net effects of the above reaction cycles are the alternations (damages) of at least two biological targets R1NH and R2NH without loss of any halogen. Similar reaction cycles can also occur for other RHS such as XO  and X2. They are most effective (i.e., cycle 2 occurs), if the DET of RN1X yields a X  atom, which was indeed observed for N-bromoimides but not for N-chloroimides. 22, 23 Cycle 2 will be more significant with the formation of X2 in reaction (1) In atmospheric photochemistry of ozone loss, RHS is removed from the catalytic cycles once the reaction ends with HX or XONO2 ("inactive reservoirs"). In the phagosome (cell), however, this is not the case as aqueous HCl can readily react with OH  /HOX to form X  /X2 and the hydrolysis of XONO2 will quickly occur to form XO  and NO2. Notably, the above proposed cyclic reactions are essentially enzyme-driven electron-transfer reactions. Peroxynitrite has a half life of 1.9 seconds at pH 7.4 and its decomposition leads to a major product nitrate (NO3 − ) and a minor product of CO3 − or NO2 with/without reaction with CO2: 16, 17 
Since the redox potential of NO2 is close to that OH  , ONOO − acts as an OH  -like oxidizing species in causing damaging effects. 16, 17 Notably, NO3 − is known to be an extremely effective scavenger for weakly-bound electrons (NO3 has an electron affinity of 3.94 eV, larger than any halogen), [25] [26] [27] as we measured the reaction rate constant being as large as 1.2(±0.5)×10 . 27 Thus, the halogen reaction cycles would be terminated if there is a significant amount of NO3 − in the phagosome. Remarkably, the reduction or removal of nitrogen species (HNO3 as the ultimate product) is a critical requirement for the formation of the polar ozone hole. 20 Here the proposed immune defence system fighting against pathogens includes three components: the H2O2 signaling pathway is the 'igniter' (trigger), the RHS reaction cycles are the 'accelerator' (amplifier), and the NO  signaling pathway is the 'brake' (terminator) of RHS reactions, as shown in Figure 1 . A delicate balance between these two important regulations by H2O2 and NO  is responsible for immunity that keeps the balanced state of multicellular organisms having adequate biological defenses to fight infection, disease, or other unwanted biological invasion, while having adequate tolerance to avoid allergy and autoimmune diseases/disorders. Note that as stable and small neutral signaling molecules that can diffuse easily across the membrane, both H2O2 and NO  from other cellular organelles such as peroxisomes and mitochondria can also involve in the defense system. The H2O2-initiated halogen cyclic reactions should greatly amplify the pathogen-killing effects of RHSs in the phagosome. This proposed mechanism might lead to discoveries or identification of highly effective antiviral drugs to kill various viruses including severely aggressive viruses like current Covid19. This mechanism also provides a long-sought solution to the challenging question in radiation biology why minor ROS/RNS induced by ionizing radiation can create significant damaging effects, compared with the levels produced from oxidative metabolism of cells. Also, this mechanism reveals that H2O2 as a signaling molecule plays the key role in killing pathogens for immunological defence in many biosystems from plants and animals to humans.
If people infected by an acute pathogen like Covid19 show mild and moderate symptoms and receive no or improper treatment, they might rapidly develop into severe cases of extreme respiratory burst. In the latter case, the halogen cyclic killing reactions may result in dysfunctions or disorders of closely interacting and communicating cell organelles, such as peroxisomes, mitochondria and lysosomes, and even severe damage to the host tissues during autoimmune (over inflammation), by analogy with the severe springtime Antarctic ozone hole. The over toxicity caused by amplified RHS reactions is expected to result in unrepairable damage or mutations to cellular components, and the signalling pathways of H2O2 and NO  may be impaired as well.
Disorders in these organelles can cause serious damage to multiple organs such as lung, heart, liver, kidney and nervous systems, and respiratory failure, septic shock, multi-organ failure, or even deaths. The best treatment should be in early or moderate stage or prevention.
Halogenated aromatic drugs as repurposed Drugs
Given our new understanding of the pathology of invading pathogens described above, we now discuss potential treatment of the severe virus Covid19. Exogenous halogenated aromatic ring compounds as neutral small molecules that can freely diffuse across membrane will be potent antipathogen agents. Here we present a new molecular mechanism of action (MOA) of a class of halogenated aromatic drugs such as chloroquine and hydroxychloroquine (HCQ), which have been a current focus for experimental treatment of Covid19, [28] [29] [30] and more potent di-amino, di-halogen aromatic ring molecules (termed femtomedicine compounds, FMDs), which have exhibited excellent targeted chemotherapy of multiple cancers. [31] [32] [33] These drugs or candidates are promising for effective treatments of covid19, cancer and other diseases.
For the MOA of HCQ and chloroquine, the readers are referred to a timing and excellent review by Schrezenmeier and Dörner. 34 As noted by the reviewers, most of the MOAs to explain the therapeutic and/or adverse effects were hypothesized based on in vitro studies, and the link between the proposed MOAs and the clinical efficacy and in vivo safety is yet to establish. The proposed molecular MOA of HCQ during autoimmunity include the following processes. Pharmacokinetic studies showed that HCQ is similar to chloroquine, with rapid gastrointestinal absorption and elimination by kidney. Cytochrome P450 enzymes metabolize HCQ to N-desethyl-HCQ. 35 Pharmadynamic studies showed that these antimalarial drugs are lipophilic weak bases, easily pass plasma membranes, and preferentially accumulates in lysosomes, causing increases in the pH of lysosomes from 4 to 6. 36 In lysosomes, HCQ inhibits the degradation of cargos (proteins and organelles) derived externally or internally in phagolysosomes by increasing the pH to prevent the activity of lysosomal enzymes. 34 Elevation in pH causes inhibition of lysosomal activity including diminished proteolysis effect, 37 decreased intracellular processing, glycosylation and secretion of proteins with many consequences. 38 These effects are believed to cause a decreased immune cell functioning such as chemotaxis, phagocytosis and O2 − production by neutrophils. 39 Another proposed MOA was that HCQ inhibits Toll-like receptor (TLR) signalling. This speculation might be traced back to a review published in 2003 by Takeda, Kaisho and Akira. 40 They reviewed potent antiviral and antitumor properties of several synthesized imidazoquinolines as nucleic acid analogs, which have ability to induce inflammatory cytokines, especially IFN-α. TLR7 was suggested to sense viral infection by recognizing a unknown viral component or product, or a host compound induced in response to virus. Also, their unpublished data showed that two other immunomodulators, loxoribine and bropirimine, also activated immune cells through TLR7. Bropirimine (2-amin-5-bromo-6-phenyl-4(3)-pyrimidinone) is an orally active immunomodulator that induces production of cytokines including IFN-α. It was in clinical use against renal cell carcinoma, but was never got approved. This is not surprizing, in view of our real-time mechanistic studies of halopyrimidines using femtosecond laser spectroscopy, 41 as further discussed below. The TLR family has been recognized as microbial components as clinically useful synthetic compounds. Thus, there is interest in searching TLR-activating agents for clinical applications. Takeda et al 40 predicted that new therapies utilizing the TLR-mediated innate immune activation would be developed to treat several disorders such as infection, cancer, and allergy. Because of some structural similarity to these imidazoquinolines, there have been speculations that the MOA of HCQ would be associated with TLR7 and TLR9 receptors. However, it appears that published studies including those just reviewed 34 have not yet directly researched on this possibility. Overall, available data suggest that HCQ and chloroquine impair or inhibit lysosomal and phagolysosome functions and subsequently immune activation. There are current efforts to identify exact molecular targets of HCQ within the lysosome, but convincing results and the identification of other molecular targets within the lysosomes have not yet reached. The precise molecular mechanisms of anti-pathogen effects these drugs remain essentially unknown.
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Molecular mechanism of action (MOA) of halogenated aromatic drugs
Here we propose a new molecular MOA of halogen-containing aromatic ring drugs represented by AXs, including HCQ and chloroquine, and a family of FMD compounds [31] [32] [33] . Here A is a quine ring system and X=Cl for HCQ and chloroquine, whereas A is an aromatic ring coupled to two NH2 groups at ortho positions [A=B(NH2)2] and X=Cln or Brn or In with n=1,2 for FMD compounds such as 4,5-dichloro/dibromo/diiodo-1,2-diaminobenzene and 4(5)-chloro/bromo/iodo-1,2-diaminobenzene. 31, 32 We propose that these molecules are highly effective for DET reactions and their action is quire similar to the formation of endogenous RHS in the phagosome. It is long known that the DET reactions of halogenated aromatic organic molecules AXs are highly effective and exothermic. [8] [9] [10] [11] [41] [42] [43] [44] The exothermic energy for the DET reaction in water is EX-D(A-X)+Ep. 10, 11, 41 Here EX is the electron affinity of a X atom (ECl=3.6 eV; EBr=3. of a halogenated aromatic ring molecule AX with a weakly-bound electron (e wb − ) in phagosomes, where e wb − is readily found in a variety of enzymes or antioxidants. For HCQ and chloroquine, A is a quine ring system and X=Cl, whereas A is an aromatic ring coupled to two NH 2 groups at ortho positions [A=B(NH 2 ) 2 ] and X=Cl n or Br n or I n with n=1,2 for FMD compounds such as 4,5-dichloro/dibromo/diiodo-1,2-diaminobenzene (shortened as FMD-2X-DAB, X=Cl, Br and I) and 4(5)-chloro/bromo/iodo-1,2-diaminobenzene (FMD-X-DAB, X=Cl, Br and I). 31, 32 Similar to the DET reactions of endogenous halogenated organic compounds, effective DET reactions of AXs can occur with the enzymes such as MPO/EPO/SOD or antioxidants NADPH:
In addition, DET reactions of AXs with O2
 can also occur with or without the involvement of enzymes in the phagolysosome. This is especially effective for brominated and iodized aromatic molecules as their DET reactions have larger exothermicities:
Correspondingly, Br  and I  atoms can most effectively be generated and have highly effective reaction cycles to amplify the biological effects. The formed reactive radical AO2  can also directly cause damaging effects, e.g., by hydrogen abstraction from DNA/RNA, lipids or proteins, while X − like endogenous halogen ions can be converted into HOX, OX  , X  and X2 via the enzymes. Like endogenous HOCl/HOBr/HOI, these exogenous RHS will have the amplifying cyclic reactions and cause significant anti-pathogen effects for immunological defence.
Potential new therapeutics
As observed for HCQ, these neutral small-molecule AXs including FMDs can easily pass plasma membranes to accumulate in lysosomes. We propose that the MOA of HCQ or chloroquine should be due to the enhanced pathogen-killing effect induced by the reaction cycles of RHS derived from the DET of the drug. Indeed, the DET reaction of these molecules will lead to an increase in the OH − (and X − ) yield in lysosomes, i.e., equivalent to a rise in pH, consistent with the observations. When there are invading pathogens in early or intermediate stages, pathogens are effectively killed in the formed phagolysosomes with excess RHS before autoimmune occurs. Since the DET reaction efficiencies are expected to increase in the order of Cl<Br<I for X in AXs, as we already observed for halopyrimidines (CldU, BrdU, IdU), 41 and more critically the DET reactions of Brand I-containing aromatic ring molecules can readily produce Br or I atoms to activate cycle 2 reactions, the in vivo therapeutic efficacy should increase in the order of ACln<<ABrn<AIn (n=1,2).
As for anti-cancer activity of AXs, similar RHS are expected to be generated and to cause cellular killing. Moreover, since both H2O2 and NO are neutral small signaling molecules that can diffuse freely across the membrane and have high mobility, similar reaction cycles of RHS are expected to take place in other intracellular organelles such as mitochondria and peroxisomes which are electron (antioxidant)-rich. Indeed, our in vitro and in vivo experimental results of multiple cancers have confirmed that the therapeutic efficacies of FMDs increases in the order of ACl2<<ABr2<AI2. 31, 32 Moreover, our unpublished data 47 obtained by direct, real-time femtosecond laser spectroscopic observations of the DET reactions of FMD compounds show that they are highly effective to generate RHS that then cause DNA damage in a well-controlled in vitro experiment.
Notably, FMD compounds B(NH2)2Xn distinguish themselves from other drugs such as HCQ and chloroquine, bropirimine, BrdU and IdU, not only by yielding highly reactive Br or I atoms to initiate the powerful H2O2-independent reaction cycles but by a unique structural characteristic that contains two neighbouring amine groups attached to the ring system. This idea is based on a previous surprising finding that the presence of ammonia can cause giant enhancements in the DET reaction efficacies of CFCs adsorbed on ice surfaces by up to 30000 times, 8, 42 which was later confirmed by others 44 (for reviews, see refs. 10 and 11). Although in vivo DET efficiencies may not be enhanced to this extent, it is promising to expect that the DET reactions of FMDs should be far more effective than any other halogenated organic molecules without the two amine groups in their structures. This was indeed observed by comparing the DET reactions of FMDs with bromodeoxyuracil (BrdU) and iododeoxyuracil (IdU). 47 BrdU is very similar to bropirimine mentioned above in structure. We predict that the in vivo anti-pathogen effectiveness of FMDs with proper formulations will be at least 10 times higher than that of any of HCQ, chloroquine, bropirimine, BrdU and IdU.
Of particular interesting is also the finding that in treated normal cells, a FMD (X=2Br) at 100 M caused an increase by about 40% of the reduced glutathione (GSH) level, which is an endogenous protective antioxidant, whereas the GSH level in human cervical (ME-180) cancer cells significantly dropped upon treated by the FMD and decreased to ~35% at 100 M FMD. 31 This marked selective depletion of the GSH was consistent with the proposed preferential DET reaction to activate in cancer cells and with the observed selective cytotoxic effects of FMDs in vitro and in vivo. [31] [32] [33] These results showed that FMDs even have a protective effect on normal cells while killing abnormal cells and can be used as targeted chemotherapeutic agents, as highlighted by Elsevier/Lancet. 48, 49 Although no tests on antiviral activity of FMDs have been performed, our new studies on animal cancer models have shown that FMDs such as 4,5-dibromo-1,2-diaminobenzene and 4,5-diiodo-1,2-diaminobenzene at doses of ≤35 mg/kg (i.p) showed a superior efficacy in anti-cancer activity (leading to significant tumor shrinkage) to the clinical drugs such as cisplatin and gemcitabine at doses that showed significant toxic side effects. In contrast, the maximum tolerated dose (MTD) of 4,5-dibromo-1,2-diaminobenzene was measured to be 240 mg/kg (i.p), and no significant multiple dose toxicity in blood, liver, kidney, gut and spleen for 90 mg/kg/week for 4 weeks in mice (i.v) were observed. The oral MTD, which is usually at least 5 times higher, is estimated to be over 1000 mg/kg. These results indicate that FMDs are essentially non-toxic but highly effective chemotherapeutic agents at used doses that can preferentially kill abnormal cells. It is therefore useful for natural targeted chemotherapy of cancer and other diseases, which potentially include viral infections and autoimmune/inflammatory disorders. By contrast, due to the increased risk of developing retinopathy during treatment with HCQ, the current ophthalmology guidelines recommend a maximal daily dose of 5.0 mg/kg (actual body weight) per day for HCQ, while in cancer studies, high HCQ doses up to 1,200 mg (~ 17-18 mg/kg) daily was prescribed. 34 Given these data, FMDs are estimated to have a clinical safe dose at least 10 times higher than HCQ in humans, and at a wide non-toxic dose range, FMDs will have outperformance over existing drugs such as chloroquine and HCQ that have a number of known toxic side effects.
During the revision of this manuscript, Caly et al. 50 report that the FDA-approved ivermectin inhibits replication of SARS-CoV-2 in vitro, making it a possible candidate for COVID-19 drug repurposing research. Interestingly, pharmacological studies showed that the drug binds to glutamate-gated chloride channels (GluCls, present in neurons and myocytes) in the membranes of invertebrate nerve and muscle cells, causing increased permeability to Cl − ions, resulting in cellular hyper-polarization, followed by paralysis and death. The pathology proposed in this paper can well explain the MOA of this drug: the increased Cl − permeability will elevate the Cl − level and the associated RHS cyclic reactions to enhance the pathogen-killing effects.
Final remarks
According to the pathology of infection and molecular MOA of drugs proposed in this paper, drugs (candidates) like HCQ and FMDs will enhance rather than inhibit the endogenous pathogenkilling effect in the immune system in humans. These halogenated aromatic drugs or candidates should be encouraged and recommended for experimental treatment of COVID19, especially for preventive, mild and moderate stages, and probably treatment of developed chronic conditions. In these applications, the halogen compounds should provide strong pathogen-killing effects. During autoimmune, however, precaution should be taken if these drugs are to be used, because they will produce an excess number of exogenous RHS, much larger than that of endogenous RHS. In the latter case, using a NO (iNOS) inducer to enhance the production of the electron killer (NO3 − , the braking molecule for halogen cyclic reactions) neutralizing RHS might be helpful to the patients. This paper provides a plausible molecular mechanism that might help the clinical practice of the drugs. It can improve the clinical efficacy, control the toxicity within a tolerated range, and suggest the optimal timing/sequential administration or possible combination therapy. This might meet the current medical challenges faced in this global pandemic and save many lives across the globe. Furthermore, this research reveals that H2O2 is the major signaling initiator and promoter of the immune system fighting against pathogens from plants to humans. The new mechanistic insights into the immune defense might lead to discovery and development of more potent and/or targeted drugs for treatment of many diseases such as virus infection, cancer and others.
